Skip to Content

Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht SUVPF Stock Quote

| Rating as of


Last close prices updated as of Mar 14, 2023, 10:35 AM EST | USD
  • Last Close 423
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Large Growth
  • Day Range 423.00  –  423.00
  • Year Range 305.00  –  490.00
  • Market Cap 28.9399 Bil
  • Volume / Avg 690.0 /  122.3
  • Price / Sales 3.22
  • Price / Book 13.50
  • Forward Div Yield 0.36%
  • Trailing Div Yield 0.64%

Morningstar‘s Stock Analysis SUVPF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SUVPF

Company Profile SUVPF

Business Description

Sartorius AG is the leading provider of biopharmaceutical fermentation and fluid management. As of 2022, the bioprocess division contributes about 80% to total revenue and the lab division the remaining 20%. The bioprocess division is traded as a separate company, Sartorius Stedim Biotech. Sartorius AG has a 74% ownership of this subsidiary with 85% voting control. In addition to biomanufacturing equipment and consumables, Sartorius offers a wide range of products for general lab use, such as scales, pipettes, and filtration equipment. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (36% of 2021 sales), the Americas (33%), and Asia-Pacific (28%). Sartorius employs over 15,000 people and has operations in more than 30 countries.

Otto-Brenner-Strasse 20
Gottingen, NI, 37079, DEU
Industry Medical Instruments & Supplies
Employees 15,942

FAQs for Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht Stock

No. SUVPF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SUVPF’s market cap is 28.94 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SUVPF’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SUVPF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SUVPF’s historical performance against its industry peers and the overall market.